Advertisement

Topics

Better know a biosimilar: extra clinical data key for Boehringer

07:21 EDT 20 Jun 2017 | thePharmaLetter

In an increasingly crowded anti-TNF market, Germany’s Boehringer Ingelheim believes that clinical data…

Original Article: Better know a biosimilar: extra clinical data key for Boehringer

NEXT ARTICLE

More From BioPortfolio on "Better know a biosimilar: extra clinical data key for Boehringer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cytokine Tumour Necrosis Factor (TNF)
TNF is a compound that is classified as a cytokine which plays a central role in the cellular mechanisms of apoptosis or cell death. However, there are a number of different kinds of TNF, just under twenty, but the family of molecules have very similar a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...